Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SLDBSolid Biosciences Inc.

Nasdaq · CIK 0001707502
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts294

Identity from submissions API

NameSolid Biosciences Inc.
CIK0001707502
TickersSLDB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN900943402
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-337-4680
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Solid Biosciences, LLC (2017-08-04T04:00:00.000Z → 2018-01-25T05:00:00.000Z)
Business address
500 RUTHERFORD AVENUE
3RD FLOOR
CHARLESTOWN
MA
02129
MA
Mailing address
500 RUTHERFORD AVENUE
3RD FLOOR
CHARLESTOWN
MA
02129
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

739 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000206 005-90280 261555740 34 12711
2026-11-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000255 005-90280 261532290 34 16226
2026-11-04 10-Q 10-Q 0001193125-26-447178 001-38360 261521964 34 11617551 1 1
2026-10-26 4 4 0001193125-26-431910 5768
2026-10-20 4 4 0001193125-26-426668 9126
2026-10-06 4 4 0001193125-26-415649 7130
2026-08-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-352656 005-90280 261283812 34 12250
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003502 005-90280 261281497 34 11431
2026-08-06 8-K 8-K 8.01,9.01 0001193125-26-338438 001-38360 261250418 34 172480 1 1
2026-08-06 424B5 424B5 0001193125-26-338410 333-287325 261250312 33 452982
2026-08-06 S-3ASR S-3ASR 0001193125-26-338387 333-298079 261250203 33 1379390 1 1
2026-08-06 10-Q 10-Q 0001193125-26-337935 001-38360 261248800 34 11088613 1 1
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002128 005-90280 261247228 34 11556
2026-07-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003093 005-90280 261221059 34 10969
2026-07-07 4 4 0001193125-26-297456 7130
2026-06-24 3 xslF345X06/form3-06242026_100619.xml 0001231919-26-000697 13781
2026-06-24 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000183 005-90280 261117144 34 16784
2026-06-11 4 4 0001193125-26-267504 5719
2026-06-11 4 4 0001193125-26-267503 5701
2026-06-11 4 4 0001193125-26-267502 5712
2026-06-11 4 4 0001193125-26-267501 10720
2026-06-11 4 4 0001193125-26-267500 5672
2026-06-11 4 4 0001193125-26-267499 5672
2026-06-11 4 4 0001193125-26-267496 5684
2026-06-11 4 4 0001193125-26-267494 5742
2026-06-11 4 4 0001193125-26-267489 5662
2026-06-10 8-K 8-K 5.07 0001193125-26-265804 001-38360 261079638 34 171016 1 1
2026-06-05 424B7 424B7 0001193125-26-259503 333-294460 261068984 33 139257
2026-05-12 10-Q 10-Q 0001193125-26-219337 001-38360 26968327 34 9689308 1 1
2026-05-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002005369-26-000031 005-90280 26940940 34 21051
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001720 005-90280 26901100 34 11020
2026-04-23 ARS ARS 0001193125-26-173719 001-38360 26888778 34 1469757
2026-04-23 DEFA14A DEFA14A 0001193125-26-173684 001-38360 26888676 34 3083645 1 1
2026-04-23 DEF 14A DEF 14A 0001193125-26-173642 001-38360 26888499 34 4145702 1 1
2026-04-21 4 4 0001193125-26-166736 6407
2026-04-21 4 4 0001193125-26-166734 6408
2026-04-21 4 4 0001193125-26-166735 6372
2026-04-21 4 4 0001193125-26-166733 6377
2026-04-21 4 4 0001193125-26-166732 6330
2026-04-21 4 4 0001193125-26-166731 6386
2026-04-10 PRE 14A PRE 14A 0001193125-26-151270 001-38360 26854973 34 4140990 1 1
2026-04-10 8-K 8-K 5.02 0001193125-26-151259 001-38360 26854940 34 143827 1 1
2026-04-02 4 4 0001193125-26-140056 7130
2026-03-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001023 333-294460 26824476 33 1879
2026-03-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001022 333-294456 26824474 33 1879
2026-03-27 CORRESP filename1.htm 0001193125-26-129212 5322
2026-03-27 CORRESP filename1.htm 0001193125-26-129206 5322
2026-03-24 UPLOAD filename1.pdf 0000000000-26-002992 333-294456 40187
2026-03-24 UPLOAD filename1.pdf 0000000000-26-002991 333-294460 40187
2026-03-19 S-3 S-3 0001193125-26-116163 333-294460 26775099 33 414621 1 1
2026-03-19 S-3 S-3 0001193125-26-116158 333-294456 26775079 33 342293 1 1
2026-03-19 S-8 S-8 0001193125-26-115985 333-294437 26774356 33 272261 1 1
2026-03-19 10-K 10-K 0001193125-26-115928 001-38360 26774134 34 16769127 1 1
2026-03-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-029671 005-90280 26764095 34 18059
2026-03-12 8-K 8-K 7.01,8.01 0001193125-26-102489 001-38360 26744653 34 188302 1 1
2026-03-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-102083 005-90280 26743168 34 14027
2026-03-11 4 4 0001193125-26-102076 10289
2026-03-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-100348 005-90280 26740238 34 134869
2026-03-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-26-000070 005-90280 26739908 34 22174
2026-03-06 8-K 8-K 1.01,2.02,3.02,8.01,9.01 0001193125-26-096709 001-38360 26731624 34 637121 1 1
2026-02-18 4 4 0001193125-26-057878 9331
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057874 001-38360 26651343 33 6158
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057873 001-38360 26651342 33 6877
2026-02-18 4 4 0001193125-26-057872 9348
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057871 001-38360 26651340 33 6831
2026-02-18 4 4 0001193125-26-057868 11317
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057867 001-38360 26651337 33 6823
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057866 001-38360 26651336 33 6887
2026-02-18 4 4 0001193125-26-057865 9337
2026-02-18 4 4 0001193125-26-057863 9370
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057862 001-38360 26651332 33 6862
2026-02-18 4 4 0001193125-26-057859 9363
2026-02-18 144 xsl144X01/primary_doc.xml 0001193125-26-057858 001-38360 26651323 33 6764
2026-02-18 4 4 0001193125-26-057855 9304
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001082 005-90280 26641081 34 14913
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000908 005-90280 26623696 34 12623
2026-02-06 4 4 0001193125-26-041523 5533
2026-02-06 4 4 0001193125-26-041519 5494
2026-02-06 4 4 0001193125-26-041516 7308
2026-02-06 4 4 0001193125-26-041514 5450
2026-02-06 4 4 0001193125-26-041511 5534
2026-02-06 4 4 0001193125-26-041507 5516
2026-02-06 4 4 0001193125-26-041506 5505
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038037 001-38360 26599955 33 6070
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038033 001-38360 26599954 33 6126
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038031 001-38360 26599953 33 6882
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038025 001-38360 26599947 33 6178
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038023 001-38360 26599944 33 6162
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038020 001-38360 26599942 33 5969
2026-02-04 144 xsl144X01/primary_doc.xml 0001193125-26-038016 001-38360 26599937 33 5376
2026-02-02 4 4 0001193125-26-034089 18155
2026-02-02 4 4 0001193125-26-034087 18208
2026-02-02 4 4 0001193125-26-034085 18219
2026-02-02 4 4 0001193125-26-034083 18473
2026-02-02 4 4 0001193125-26-034080 18242
2026-02-02 4 4 0001193125-26-034076 18207
2026-02-02 4 4 0001193125-26-034072 13763
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-034070 001-38360 26589734 33 5437
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-034069 001-38360 26589733 33 4750
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-034066 001-38360 26589731 33 5371
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-034065 001-38360 26589730 33 5478
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-034060 001-38360 26589721 33 5461
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-034059 001-38360 26589717 33 5424
2026-01-30 4 4 0001193125-26-031765 13765
2026-01-13 4 4 0001193125-26-011873 8994
2026-01-13 144 xsl144X01/primary_doc.xml 0001193125-26-011869 001-38360 26530709 33 4675
2026-01-07 4 4 0001193125-26-006287 11962
2026-01-06 4 4 0001193125-26-004953 10606
2025-12-04 4 4 0001193125-25-308118 8833
2025-12-04 4 4 0001193125-25-308115 8999
2025-12-04 4 4 0001193125-25-308108 8816
2025-12-04 4 4 0001193125-25-308103 9065
2025-12-03 144 xsl144X01/primary_doc.xml 0001193125-25-306931 001-38360 251547319 33 4778
2025-11-13 4 4 0001193125-25-280126 6908
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004892 005-90280 251475754 34 12543
2025-11-03 10-Q 10-Q 0001193125-25-262818 001-38360 251445280 34 13301523 1 1
2025-11-03 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-25-262795 001-38360 251445206 34 17742756 1 1
2025-10-21 4 4 0001193125-25-245090 8990
2025-10-07 4 4 0001193125-25-233445 7383
2025-08-18 4 4 0000950170-25-109749 7962
2025-08-18 4 4 0000950170-25-109736 7814
2025-08-18 4 4 0000950170-25-109735 7737
2025-08-18 4 4 0000950170-25-109734 7784
2025-08-18 4 4 0000950170-25-109729 7809
2025-08-18 4 4 0000950170-25-109728 7793
2025-08-18 4 4 0000950170-25-109723 7779
2025-08-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-022028 005-90280 251221544 34 17420
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000015 005-90280 251220853 34 11089
2025-08-12 10-Q 10-Q 0000950170-25-107279 001-38360 251206536 34 12927662 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003129 005-90280 251132316 34 10880
2025-07-08 4 4 0000950170-25-094690 7390
2025-06-18 4 4 0000950170-25-087881 5538
2025-06-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011689 5559
2025-06-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011688 10445
2025-06-13 4 4 0000950170-25-086248 5574
2025-06-13 4 4 0000950170-25-086244 5540
2025-06-13 4 4 0000950170-25-086238 5588
2025-06-13 4 4 0000950170-25-086236 5550
2025-06-13 4 4 0000950170-25-086234 5578
2025-06-13 4 4 0000950170-25-086232 5605
2025-06-13 8-K 8-K 5.02,5.07,9.01 0000950170-25-086215 001-38360 251046894 34 177658 1 1
2025-06-13 S-8 S-8 0000950170-25-086128 333-288022 251046357 33 1328431 1 1
2025-05-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001745 333-287325 25991038 33 1879
2025-05-22 CORRESP filename1.htm 0001193125-25-124809 5317
2025-05-21 UPLOAD filename1.pdf 0000000000-25-005441 333-287325 40297
2025-05-15 8-K 8-K 8.01,9.01 0000950170-25-072792 001-38360 25954704 34 555682 1 1
2025-05-15 424B5 424B5 0000950170-25-072786 333-277871 25954583 33 772353
2025-05-15 S-3 S-3 0001193125-25-120849 333-287325 25954386 33 1268229
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002394 005-90280 25953138 34 10980
2025-05-15 10-Q 10-Q 0000950170-25-072560 001-38360 25952567 34 11935742 1 1
2025-05-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002242 005-90280 25932861 34 15845
2025-04-25 ARS ARS 0001193125-25-096730 001-38360 25873787 34 2932632
2025-04-25 DEFA14A DEFA14A 0001193125-25-096721 001-38360 25873729 34 1293596
2025-04-25 DEF 14A DEF 14A 0001193125-25-096695 001-38360 25873649 34 3599212 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-055669 005-90280 25848827 34 18531
2025-04-11 PRE 14A PRE 14A 0001193125-25-079183 001-38360 25833211 34 3602713 1 1
2025-04-08 4 4 0000950170-25-052050 7390
2025-03-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000697 333-285613 25742169 33 1886
2025-03-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000696 333-285611 25742153 33 1886
2025-03-13 4 4 0000950170-25-038706 4477
2025-03-12 CORRESP filename1.htm 0001193125-25-052907 5200
2025-03-12 CORRESP filename1.htm 0001193125-25-052904 5191
2025-03-11 UPLOAD filename1.pdf 0000000000-25-002661 333-285611 40201
2025-03-11 UPLOAD filename1.pdf 0000000000-25-002660 333-285613 40202
2025-03-06 S-3 S-3 0001193125-25-048496 333-285613 25716178 33 258787
2025-03-06 S-3 S-3 0001193125-25-048487 333-285611 25716117 33 246365
2025-03-06 S-8 S-8 0001193125-25-048452 333-285603 25715802 33 81699
2025-03-06 10-K 10-K 0000950170-25-034644 001-38360 25715373 34 19530726 1 1
2025-02-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-008201 005-90280 25662978 34 17380
2025-02-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-025036 005-90280 25653529 34 17670
2025-02-21 4 4 0000950170-25-025011 46336
2025-02-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003153 12108
2025-02-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-005065 005-90280 25652069 34 23395
2025-02-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-024858 005-90280 25652066 34 13649
2025-02-21 4 xslF345X05/form4-02212025_090218.xml 0001415889-25-005059 12008
2025-02-19 4 xslF345X05/ownership.xml 0000902664-25-001114 9670
2025-02-19 3 xslF345X02/ownership.xml 0000902664-25-001113 8396
2025-02-18 8-K 8-K 1.01,8.01,9.01 0001193125-25-028691 001-38360 25635867 34 554241 1 1
2025-02-18 424B5 424B5 0001193125-25-028685 333-277871 25635822 33 676966
2025-02-18 FWP FWP 0001193125-25-028658 333-277871 25635606 34 96981
2025-02-18 4 4 0000950170-25-022206 8820
2025-02-18 4 4 0000950170-25-022203 8838
2025-02-18 4 4 0000950170-25-022202 8775
2025-02-18 4 4 0000950170-25-022201 8809
2025-02-18 4 4 0000950170-25-022196 8840
2025-02-18 4 4 0000950170-25-022200 8801
2025-02-18 4 4 0000950170-25-022199 10790
2025-02-18 8-K 8-K 8.01 0001193125-25-028146 001-38360 25632719 34 150905 1 1
2025-02-18 8-K 8-K 2.02,8.01,9.01 0001193125-25-028123 001-38360 25632682 34 9562250 1 1
2025-02-14 144 xsl144X01/primary_doc.xml 0000950170-25-021491 001-38360 25631132 33 5317
2025-02-14 144 xsl144X01/primary_doc.xml 0000950170-25-021490 001-38360 25631128 33 5278
2025-02-14 144 xsl144X01/primary_doc.xml 0000950170-25-021485 001-38360 25631091 33 5230
2025-02-14 144 xsl144X01/primary_doc.xml 0000950170-25-021482 001-38360 25631075 33 5337
2025-02-14 144 xsl144X01/primary_doc.xml 0000950170-25-021474 001-38360 25631020 33 5289
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001654954-25-001500 005-90280 25623472 34 12854
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-018909 005-90280 25615279 34 18614
2025-02-11 4 4 0000950170-25-017979 18050
2025-02-11 4 4 0000950170-25-017978 18875
2025-02-11 4 4 0000950170-25-017977 5716
2025-02-11 4 4 0000950170-25-017974 17983
2025-02-11 4 4 0000950170-25-017971 18913
2025-02-11 4 4 0000950170-25-017962 18529
2025-02-11 4 4 0000950170-25-017959 19332
2025-01-29 4 4 0000950170-25-010625 13782
2025-01-13 4 4 0000950170-25-004971 8897
2025-01-07 4 4 0000950170-25-003054 10613
2025-01-07 4 4 0000950170-25-003052 11975
2024-12-05 144/A xsl144X01/primary_doc.xml 0000950170-24-133671 001-38360 241529105 33 4605
2024-12-04 4 4 0000950170-24-133369 8697
2024-12-04 144 xsl144X01/primary_doc.xml 0000950170-24-133368 001-38360 241527182 33 4590
2024-12-04 4 4 0000950170-24-133360 8883
2024-12-04 4 4 0000950170-24-133340 8671
2024-12-04 4 4 0000950170-24-133317 8889
2024-12-03 144 xsl144X01/primary_doc.xml 0000950170-24-132905 001-38360 241523899 33 4614
2024-11-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019353 5566
2024-11-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019352 10304
2024-11-14 SC 13D/A SC 13D/A 0001193125-24-259014 005-90280 241465344 34 84933
2024-11-14 SC 13G SOLID BIOSCIENCES INC. 0000902664-24-006562 005-90280 241459139 34 67774
2024-11-14 SC 13G/A e664011_sc13ga-sb.htm 0001193805-24-001357 005-90280 241457520 34 100403
2024-11-12 SC 13G/A SC 13G/A 0001193125-24-256066 005-90280 241449528 34 147092
2024-11-12 SC 13G/A SOLID BIOSCIENCES INC. 0000902664-24-006394 005-90280 241444174 34 71546
2024-11-06 10-Q 10-Q 0000950170-24-122247 001-38360 241430802 34 9453268 1 1
2024-11-01 SC 13G/A SLDB_SC13GA1.htm 0001273087-24-000112 005-90280 241419188 34 81926
2024-10-22 4 4 0000950170-24-116246 8804
2024-10-04 4 4 0000950170-24-112898 7345
2024-08-13 10-Q 10-Q 0000950170-24-096130 001-38360 241201222 34 8450411 1 1
2024-08-02 SC 13G/A SC 13G/A 0001193125-24-193051 005-90280 241172636 34 185127
2024-07-05 4 4 0000950170-24-081866 7345
2024-06-13 4 4 0000950170-24-073013 5581
2024-06-13 4 4 0000950170-24-073006 5581
2024-06-13 4 4 0000950170-24-073003 5615
2024-06-13 4 4 0000950170-24-073000 5547
2024-06-13 4 4 0000950170-24-072998 5595
2024-06-13 4 4 0000950170-24-072996 5557
2024-06-13 4 4 0000950170-24-072992 5585
2024-06-12 SC 13D/A SC 13D/A 0001104659-24-070940 005-90280 241039602 34 85139
2024-06-11 SC 13D/A SC 13D/A 0001193125-24-159367 005-90280 241037312 34 95486
2024-06-11 8-K 8-K 5.02,5.07,9.01 0001193125-24-159143 001-38360 241036077 34 174339 1 1
2024-06-11 S-8 S-8 0001193125-24-159100 333-280116 241035746 33 195842
2024-06-11 4 4 0000950170-24-071765 4480
2024-06-05 SC 13G SLDB_SC13G.htm 0001273087-24-000076 005-90280 241022128 34 81867
2024-05-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-17 09:30:00 9999999995-24-001565 333-277871 24962240 33 1886
2024-05-15 CORRESP filename1.htm 0001193125-24-138935 5215
2024-05-15 S-3/A S-3/A 0001193125-24-138930 333-277871 24947320 33 687245
2024-05-15 10-Q 10-Q 0000950170-24-060034 001-38360 24947154 34 6796726 1 1
2024-05-06 4 4 0000950170-24-053774 10557
2024-04-26 ARS ARS 0001193125-24-118115 001-38360 24884082 34 2369620
2024-04-26 DEFA14A DEFA14A 0001193125-24-118095 001-38360 24884037 34 1094194
2024-04-26 DEF 14A DEF 14A 0001193125-24-118079 001-38360 24883936 34 2663367
2024-04-12 PRE 14A PRE 14A 0001193125-24-094654 001-38360 24841578 34 2663836
2024-04-05 4 4 0000950170-24-042322 7338
2024-03-18 UPLOAD filename1.pdf 0000000000-24-002924 333-277871 40412
2024-03-13 S-3 S-3 0001193125-24-066471 333-277871 24744736 33 1468366
2024-03-13 S-8 S-8 0001193125-24-066438 333-277869 24744676 33 89996
2024-03-13 10-K 10-K 0000950170-24-030508 001-38360 24744577 34 13539745 1 1
2024-02-16 4 4 0000950170-24-016220 8037
2024-02-16 4 4 0000950170-24-016219 7968
2024-02-16 4 4 0000950170-24-016216 8059
2024-02-16 4 4 0000950170-24-016213 7981
2024-02-16 4 4 0000950170-24-016193 7955
2024-02-16 4 4 0000950170-24-016192 8019
2024-02-16 4 4 0000950170-24-016185 8870
2024-02-16 4 4 0000950170-24-016180 5746
2024-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-08 16:30:00 9999999995-24-000361 333-276764 24610962 33 1886
2024-02-07 SC 13G SOLID BIOSCIENCES INC. 0000902664-24-001231 005-90280 24605886 34 99927
2024-02-06 CORRESP filename1.htm 0001193125-24-025326 7097
2024-02-05 UPLOAD filename1.pdf 0000000000-24-001365 333-276764 40459
2024-01-30 4 4 0000950170-24-008971 13605
2024-01-30 S-3 S-3 0001193125-24-019409 333-276764 24578226 33 336944
2024-01-22 SC 13G SC 13G 0001193125-24-012203 005-90280 24549205 34 150127
2024-01-19 3 3 0000950170-24-005896 6504
2024-01-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-000843 12107
2024-01-12 SC 13D/A SC 13D/A 0001193125-24-007643 005-90280 24532789 34 81400
2024-01-12 4 4 0000950170-24-004289 41163
2024-01-12 SC 13D/A SC 13D/A 0001193125-24-007632 005-90280 24532738 34 122862
2024-01-12 4 OWNERSHIP DOCUMENT 0001104659-24-003747 13860
2024-01-12 4 4 0000950170-24-004276 6163
2024-01-12 SC 13G e619187_sc13g-sb.htm 0001193805-24-000044 005-90280 24531931 34 102488
2024-01-11 4 4 0000950170-24-004007 8853
2024-01-11 SC 13D/A SC 13D/A 0001104659-24-003373 005-90280 24530033 34 93448
2024-01-10 SC 13D/A SC 13D/A 0001193125-24-005969 005-90280 24526943 34 89971
2024-01-08 8-K 8-K 1.01,2.02,3.02,7.01,8.01,9.01 0001193125-24-003882 001-38360 24518329 34 3715448 1 1
2024-01-05 4 4 0000950170-24-002599 10612
2024-01-05 4 4 0000950170-24-002598 12336
2023-12-05 4 4 0000950170-23-068076 8602
2023-12-05 4 4 0000950170-23-068068 9103
2023-12-05 4 4 0000950170-23-068067 8593
2023-12-05 4 4 0000950170-23-068065 8604
2023-12-05 4 4 0000950170-23-068064 8617
2023-12-05 4 4 0000950170-23-068063 8599
2023-11-15 8-K 8-K 7.01,8.01,9.01 0001193125-23-277552 001-38360 231409068 34 176835 1 1
2023-11-08 10-Q 10-Q 0000950170-23-061096 001-38360 231387872 34 8571279 1 1
2023-10-20 4 4 0000950170-23-054388 7898
2023-10-20 3 3 0000950170-23-054381 15792
2023-10-05 4 4 0000950170-23-052171 7241
2023-09-06 4 4 0000950170-23-046760 9154
2023-08-14 10-Q 10-Q 0000950170-23-042371 001-38360 231169658 34 9454106 1 1
2023-07-06 4 4 0000950170-23-031954 7253
2023-06-09 8-K 8-K 5.02,5.07,9.01 0001193125-23-164486 001-38360 231005802 34 163337 1 1
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015008 5707
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015007 5683
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015004 5741
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-015002 5721
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014999 17429
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014998 10202
2023-06-08 4 FORM 4 SUBMISSION 0000899243-23-014997 5674
2023-06-08 4 OWNERSHIP DOCUMENT 0001104659-23-069467 13957
2023-06-08 4 4 0000950170-23-027058 5449
2023-06-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-013156 5480
2023-06-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-013155 10152
2023-06-06 S-8 S-8 0001193125-23-161658 333-272456 23996514 33 104811
2023-05-22 8-K 8-K 5.02 0001193125-23-150518 001-38360 23944966 34 152842 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020851 001-38360 23908876 34 8193208 1 1
2023-04-27 ARS ARS 0000950170-23-015342 001-38360 23857896 34 4328254
2023-04-27 DEFA14A DEFA14A 0000950170-23-015340 001-38360 23857858 34 4045792
2023-04-27 DEF 14A DEF 14A 0000950170-23-015304 001-38360 23857373 34 4560679
2023-03-23 424B5 424B5 0001193125-23-077312 333-258859 23754489 33 13662
2023-03-23 S-8 S-8 0001193125-23-077308 333-270765 23754487 33 70220
2023-03-23 10-K 10-K 0000950170-23-009318 001-38360 23754471 34 15843588 1 1
2023-03-20 8-K 8-K 7.01,9.01 0001193125-23-074426 001-38360 23744945 34 755698 1 1
2023-03-13 8-K 8-K 7.01 0001193125-23-068478 001-38360 23725703 34 146313 1 1
2023-03-06 4 FORM 4 SUBMISSION 0000899243-23-007270 9263
2023-02-13 SC 13G/A SLDB_13G_20230213.htm 0001461790-23-000010 005-90280 23619189 34 106583
2023-02-13 SC 13G/A d8831836_13g-a.htm 0000919574-23-000936 005-90280 23614956 34 107191
2023-02-10 SC 13G/A sldb13ga2022.htm 0000935836-23-000090 005-90280 23607659 34 47036
2023-02-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-02-06 16:30:00 9999999995-23-000289 333-269424 23592628 33 1837
2023-02-03 SC 13D/A SC 13D/A 0001193125-23-024221 005-90280 23586479 34 74392
2023-02-02 CORRESP filename1.htm 0001193125-23-022966 5746
2023-02-01 UPLOAD filename1.pdf 0000000000-23-001035 40309
2023-01-31 4 FORM 4 SUBMISSION 0000899243-23-003085 9358
2023-01-31 4 FORM 4 SUBMISSION 0000899243-23-003084 16413
2023-01-26 S-3 S-3 0001193125-23-016271 333-269424 23558126 33 357946
2023-01-11 4 FORM 4 SUBMISSION 0000899243-23-001614 8192
2023-01-11 3 FORM 3 SUBMISSION 0000899243-23-001612 7782
2023-01-09 S-8 S-8 0001193125-23-004679 333-269162 23517886 33 95255
2023-01-09 8-K 8-K 2.02,5.02,7.01,8.01,9.01 0001193125-23-004189 001-38360 23516696 34 7254424 1 1
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001135 13076
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001134 12511
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001133 8453
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038700 5522
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038696 6404
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038694 10169
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038693 10235
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038686 10155
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038685 10201
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038682 10250
2022-12-15 4 FORM 4 SUBMISSION 0000899243-22-038681 10221
2022-12-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023965 5315
2022-12-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023964 9987
2022-12-15 4 OWNERSHIP DOCUMENT 0001104659-22-127383 13798
2022-12-12 SC 13G PRIMARY DOCUMENT 0001654954-22-016350 005-90280 221456404 34 67361
2022-12-09 D xslFormDX01/primary_doc.xml 06b 0001707502-22-000003 021-467084 221454797 33 19949
2022-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023430 16482
2022-12-06 SC 13D/A SC 13D/A 0001193125-22-299431 005-90280 221448149 34 103926
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037694 13367
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037693 9522
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037688 8273
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037686 8273
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037684 8264
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037682 8273
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037681 10062
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037677 7818
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037675 7737
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037674 7787
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037673 7816
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037670 7717
2022-12-05 4 FORM 4 SUBMISSION 0000899243-22-037648 5526
2022-12-05 SC 13D/A SC 13D/A 0001104659-22-124600 005-90280 221445816 34 83868
2022-12-05 4 OWNERSHIP DOCUMENT 0001104659-22-124599 16543
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037642 4909
2022-12-05 3 FORM 3 SUBMISSION 0000899243-22-037640 18333
2022-12-05 SC 13D/A SC 13D/A 0001193125-22-298472 005-90280 221445292 34 109881
2022-12-05 8-K 8-K 1.01,2.01,2.05,3.02,5.02,7.01,9.01 0001193125-22-298016 001-38360 221443771 34 915812 1 1
2022-12-02 S-8 S-8 0001193125-22-297087 333-268643 221440282 33 139890
2022-12-01 8-K 8-K 5.02,5.07,8.01,9.01 0001193125-22-296577 001-38360 221439237 34 288801 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024163 001-38360 221374957 34 9025209 1 1
2022-11-07 DEFM14A DEFM14A 0001140361-22-040359 001-38360 221366523 34 8829788
2022-10-28 PREM14A PREM14A 0001140361-22-038874 001-38360 221342701 34 8799880
2022-10-27 8-K 8-K 3.03,5.03,9.01 0001193125-22-271105 001-38360 221338206 34 172366 1 1
2022-10-04 SC 13D/A SC 13D/A 0001104659-22-105935 005-90280 221293019 34 93637
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052331 7377
2022-10-03 SC 13D/A SC 13D/A 0001193125-22-256775 005-90280 221288398 34 41260
2022-09-30 DEFA14A DEFA14A 0001193125-22-255498 001-38360 221284124 34 282855
2022-09-30 8-K 8-K 7.01,9.01 0001193125-22-255495 001-38360 221284102 34 452475 1 1
2022-09-30 DEFA14A DEFA14A 0001193125-22-254812 001-38360 221282201 34 11948556
2022-09-30 8-K 8-K 1.01,3.02,5.02,7.01,8.01,9.01 0001193125-22-254807 001-38360 221282198 34 12471772 1 1
2022-09-06 SC 13D/A SC 13D/A 0001104659-22-097897 005-90280 221228826 34 74756
2022-09-02 SC 13D/A SC 13D/A 0001193125-22-237966 005-90280 221225846 34 59285
2022-09-01 SC 13G 13G_SLDB_20220831.htm 0001461790-22-000021 005-90280 221219023 34 106342
2022-08-18 SC 13D/A SC 13D/A 0001193125-22-224182 005-90280 221178009 34 34206
2022-08-11 8-K 8-K 2.02,9.01 0001193125-22-218018 001-38360 221153765 34 173988 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016643 001-38360 221153701 34 8519388 1 1
2022-07-08 SC 13G us83422e1055_070822.txt 0000834237-22-010295 005-90280 221075013 34 12320
2022-07-06 4 FORM 4 SUBMISSION 0001209191-22-041164 7332
2022-06-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014590 5397
2022-06-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014589 8274
2022-06-09 4 OWNERSHIP DOCUMENT 0001104659-22-069744 12100
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035465 5678
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035463 5644
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035461 5658

Latest XBRL company facts

One latest value per concept from companyfacts (294 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 111.61M 2026-10-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
dei EntityPublicFloat Entity Public Float USD 317.70M 2025-06-30 2025 FY 10-K 2026-03-19 0001193125-26-115928
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.48M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173642
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.46M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173642
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 7.79M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173642
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.22M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173642
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 104.83 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-173642
ffd NetFeeAmt NetFeeAmt USD 0 2026-08-04 S-3ASR 2026-08-06 0001193125-26-338387
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-08-04 S-3ASR 2026-08-06 0001193125-26-338387
ffd TtlOfferingAmt TtlOfferingAmt USD 0 2026-08-04 S-3ASR 2026-08-06 0001193125-26-338387
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-3ASR 2026-08-06 0001193125-26-338387
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-04 S-3ASR 2026-08-06 0001193125-26-338387
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.23M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 110,000 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009318
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 8.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 20.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 14.19M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -161,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.47B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.15M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4.78M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 147.10M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 16.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 14.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap Assets Assets USD 389.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AssetsCurrent Assets, Current USD 365.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 339.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AssetsNoncurrent Assets, Noncurrent USD 24.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 161,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 223.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 40.75M 2019-03-31 2019 Q1 10-Q 2019-05-13 0001564590-19-018869
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 88.50M 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 88.49M 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 222.96M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 222.96M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 173,000 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 859,000 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 1.13M 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 276,000 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 300,000 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 276,000 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 276,000 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 276,000 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042546
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 125.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 348.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 127.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 65.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 116.81M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 49.35 2020-11-30 2023 Q1 10-Q 2023-05-11 0000950170-23-020851
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 480.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 111.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 111.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CommonStockValue Common Stock, Value, Issued USD 112,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap CommonUnitAuthorized Common Unit, Authorized shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap CommonUnitIssued Common Unit, Issued shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -117.22M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -1.06M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -165.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ContractualObligation Contractual Obligation USD 8.62M 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 278,000 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 1.51M 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 2.21M 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 2.29M 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 2.33M 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 8.08M 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009318
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 10.36M 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009963
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 45,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029118
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 2.43M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.69M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 195.74M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 68.30M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 71.60M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 52,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 31.82M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 5.59M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 11.17M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 190.44M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 5.31M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 600,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap DepositAssets Deposit Assets USD 1.83M 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap Depreciation Depreciation USD 2.58M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap DerivativeLiabilities Derivative Liability USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.22 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-04-27 0001564590-22-015867
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.281 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.066 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.063 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.027 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.017 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 18.53M 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029118
us-gaap ExchangeFees Exchange Fees USD 517,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020851
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-04-27 0001564590-22-015867
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-04-27 0001564590-22-015867
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 340,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 91,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 525,000 2021-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009963
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 651,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 651,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 300,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042546
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 300,000 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 651,000 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009318
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 69,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042546
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 242,000 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 13,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 441,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -374,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 89,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 38.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122247
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -174.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -174.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 48.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -36.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 939,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 4.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -110,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -8.08M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap IncreaseDecreaseInLeasingReceivables Increase (Decrease) in Leasing Receivables USD -823,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -731,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap InterestExpense Interest Expense USD 183,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0000950170-24-096130
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD -208,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -27,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044656
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 8.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap LeaseCost Lease, Cost USD 3.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 30.05M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 358,000 2020-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.28M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 686,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042546
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.49M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 4.36M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.28M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 592,000 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042546
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 8.88M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap Liabilities Liabilities USD 47.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 389.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap LiabilitiesCurrent Liabilities, Current USD 30.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 17.34M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009318
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 1.32M 2018-04-01 2018-04-30 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap MembersCapital Members' Capital USD 65.01M 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap MembersEquity Members' Equity USD -59.26M 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 303.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -92.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -145.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -53.58M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001564590-21-053726
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -75.68M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061096
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OperatingExpenses Operating Expenses USD 172.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -172.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 21.16M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 17.34M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 20.02M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 7.74M 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.41M 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 778,000 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 686,000 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.42M 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.44M 2019-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 271,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029118
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.93M 2018-12-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042546
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.108 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 248,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 92,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 96,000 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap OtherNoncashIncome Other Noncash Income USD 22,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072560
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 585,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PaymentsForProceedsFromAvailableforsaleSecuritiesShortterm Payments for (Proceeds from) Available-for-sale Securities, Short-term USD -236.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PaymentsForRestructuring Payments for Restructuring USD 143,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 13.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 18.74M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029118
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 328.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 401,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022357
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 813,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PreferredStockDividendsPerShareDeclared Preferred Stock, Dividends Per Share, Declared USD/shares 0 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 15.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 133.69M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.97M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 3.42M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007462
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 10.65M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009963
us-gaap ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans Proceeds from Repayment of Loans by Employee Stock Ownership Plans USD 291,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 85,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 225,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 22,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -165.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 18.36M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap RelatedPartyCosts Related Party Costs USD 1.47M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009318
us-gaap RepaymentsOfLongTermDebtAndCapitalSecurities Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 134.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap RestrictedCash Restricted Cash USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 638,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 708,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.18 2022-11-01 2022-11-30 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap RestructuringCharges Restructuring Charges USD -63,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034644
us-gaap RestructuringReserve Restructuring Reserve USD 62,000 2020-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.12B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 1.93M 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020851
us-gaap Revenues Revenues USD 8.09M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009318
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap SeveranceCosts1 Severance Costs USD 5.70M 2022-10-01 2022-12-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060034
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.952 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.142 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.117 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.046 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 2.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.81M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 14.97 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 17,119 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 16,031 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10.08 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 5.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 10.08 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 37.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.8 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 342.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 126.48M 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.015 2022-10-27 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap StockIssued1 Stock Issued USD 9.17M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 40,131 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 9.17M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030508
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 124.18M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013153
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 291,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 135.37M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 0 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009963
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 147,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap SubleaseIncome Sublease Income USD 931,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 959,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001564590-20-010247
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 59.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115928
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 134.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 112.61M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-04-27 0001564590-22-015867
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 134.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447178

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →